Cilengitide (EMD 121974, NSC 707544) in asymptomatic metastatic castration resistant prostate cancer patients: A randomized phase II trial by the prostate cancer clinical trials consortium

  • Deborah A. Bradley
  • , Stephanie Daignault
  • , Charles J. Ryan
  • , Robert S. DiPaola
  • , David C. Smith
  • , Eric Small
  • , Mitchell E. Gross
  • , Mark N. Stein
  • , Alice Chen
  • , Maha Hussain

Research output: Contribution to journalArticlepeer-review

47 Scopus citations

Fingerprint

Dive into the research topics of 'Cilengitide (EMD 121974, NSC 707544) in asymptomatic metastatic castration resistant prostate cancer patients: A randomized phase II trial by the prostate cancer clinical trials consortium'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science